Treating dyslipidaemia and hypertension – A practical clinical approach
Single pill combination of bisoprolol fumarate and perindopril arginine protects patients against cardiovascular events and reduces pill burden, improving compliance
You will learn:
- β-blockers, in combination, are recommended for blood pressure control in patients with compelling indications such as when heart rate control is required in patients with coronary artery disease
- Low treatment adherence is a major cause of low blood pressure control for primary and secondary prevention. Treatment with single pill combination (SPC) increases adherence, facilitates achievement of treatment targets, and may improve outcomes
- The SPC of bisoprolol fumarate and perindopril arginine is the first and only SPC of a β-blocker and an ACE inhibitor
- SPC of bisoprolol fumarate and perindopril arginine protects patients against cardiovascular events and is a convenient solution to reduce pill burden and improve compliance.
For additional reading click on the articles below: